Answers are grounded in this paper and cite their sources.
Demonstrates accurate serum free glycoside measurement using TDx assay in patients receiving beta-methyldigoxin, highlighting clinical utility over total levels.
The presence of endogenous digoxin-like immunoreactive substance (DLIS) has been reported in several clinical conditions. Because DLIS is absent in protein-free ultrafiltrates of sera, the monitoring of the serum free glycoside concentrations (f-SGC) rather than the total glycoside concentrations (t-SGC) seems more appropriate. We conducted the present study to obtain basic information about monitoring f-SGC in patients receiving beta-methyldigoxin (BMD), using TDx digoxin assay.The results showed that accuracy of the f-SGC detected with TDx assay is almost equal to t-SGC. Additionally, although the BMD-digoxin ratio has some influence on the evaluation of f-SGC, the impact seemed negligible if individual variance in the albumin concentration is taken into account. These findings suggest that the monitoring of f-SGC rather than t-SGC, is satisfactorily applicable in clinical situations.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: